Literature DB >> 16904542

Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation.

Maurizio Gasparini1, Angelo Auricchio, François Regoli, Cecilia Fantoni, Mihoko Kawabata, Paola Galimberti, Daniela Pini, Carlo Ceriotti, Edoardo Gronda, Catherine Klersy, Simona Fratini, Helmut H Klein.   

Abstract

OBJECTIVES: The goal of this study was to investigate the effects of cardiac resynchronization therapy (CRT) in heart failure patients with permanent atrial fibrillation (AF) and the role of atrioventricular junction (AVJ) ablation.
BACKGROUND: Cardiac resynchronization therapy has been proven effective in heart failure patients with sinus rhythm (SR). However, little is known about the effects of CRT in heart failure patients with permanent AF.
METHODS: Efficacy of CRT on ventricular function, exercise performance, and reversal of maladaptive remodeling process was prospectively compared in 48 patients with permanent AF in whom ventricular rate was controlled by drugs, thus resulting in apparently adequate delivery of biventricular pacing (>85% of pacing time), and in 114 permanent AF patients, who had undergone AVJ ablation (100% of resynchronization therapy delivery). The clinical and echocardiographic long-term outcomes of both groups were compared with those of 511 SR patients treated with CRT.
RESULTS: Both SR and AF groups showed significant and sustained improvements of all assessed parameters (model p < 0.001 for all parameters). However, within the AF group, only patients who underwent ablation showed a significant increase of ejection fraction (p < 0.001), reverse remodeling effect (p < 0.001), and improved exercise tolerance (p < 0.001); no improvements were observed in AF patients who did not undergo ablation.
CONCLUSIONS: Heart failure patients with ventricular conduction disturbance and permanent AF treated with CRT showed large and sustained long-term (up to 4 year) improvements of left ventricular function and functional capacity, similar to patients in SR, only if AVJ ablation was performed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16904542     DOI: 10.1016/j.jacc.2006.03.056

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  62 in total

1.  Impact of chronic atrial fibrillation in patients with severe heart failure and indication for CRT: data of two registries with 711 patients (1999-2006 and 2007-6/2008).

Authors:  G Luedorff; R Grove; M Kowalski; E Wolff; J Thale; W Kranig
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2011-12

2.  [Pacemaker ECG quiz no. 22. A CRT non-responder with atrial fibrillation].

Authors:  C W Israel
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2010-06

3.  R/S Ratio Variability in Lead V1 Observed between Selected Four 1-Minute ECG Fragments of 24-Hour ECG as a Predictor of Incomplete Resynchronization during Full 24-Hour ECG: Pilot Study.

Authors:  Dominika Pyszno-Prokopowicz; Rafał Baranowski; Robert Bodalski; Magdalena Madej; Ryszard Piotrowicz
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-10-30       Impact factor: 1.468

Review 4.  Atrioventricular junction ablation and pacemaker implantation for heart failure associated with atrial fibrillation: potential issues and therapies in the setting of acute heart failure syndrome.

Authors:  Jason C Rubenstein; James A Roth
Journal:  Heart Fail Rev       Date:  2011-09       Impact factor: 4.214

5.  A role for cardiac resynchronization therapy in heart failure patients with atrial fibrillation.

Authors:  Padmini Varadarajan; Ramdas G Pai; Gerald M Pohost
Journal:  Curr Cardiol Rep       Date:  2006-11       Impact factor: 2.931

6.  Nonpharmacological Treatment of Atrial Fibrillation: What Is the Role of Device Therapy?

Authors:  Lucie Riedlbauchová; Václav Durdil; Jakub Honěk; Josef Veselka
Journal:  Int J Angiol       Date:  2020-04-28

Review 7.  Effects of cardiac resynchronization therapy on ventricular remodeling.

Authors:  Hind W Rahmouni; James N Kirkpatrick; Martin G St John Sutton
Journal:  Curr Heart Fail Rep       Date:  2008-03

Review 8.  Atrial fibrillation in congestive heart failure.

Authors:  Steven A Lubitz; Emelia J Benjamin; Patrick T Ellinor
Journal:  Heart Fail Clin       Date:  2010-04       Impact factor: 3.179

9.  Cardiac resynchronization therapy.

Authors:  Joseph S Owen; Sammy Khatib; Daniel P Morin
Journal:  Ochsner J       Date:  2009

10.  Expanding indications for resynchronization therapy.

Authors:  Christophe Leclercq; Nathalie Behar; Philippe Mabo; Jean-Claude Daubert
Journal:  Curr Cardiol Rep       Date:  2012-10       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.